These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hypertrophic obstructive cardiomyopathy: current treatment, indications and results]. Delahaye JP; Azzano O Presse Med; 1994 May; 23(20):925-7. PubMed ID: 7937627 [TBL] [Abstract][Full Text] [Related]
3. Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy. Yoerger DM; Weyman AE Rev Cardiovasc Med; 2003; 4(4):199-215. PubMed ID: 14668688 [TBL] [Abstract][Full Text] [Related]
4. [Hypertrophic cardiomyopathy (HCM). Surgical versus drug therapy]. Schulte HD; Gramsch-Zabel H; Schwartzkopff B; Gams E Z Kardiol; 1999 Mar; 88(3):163-72. PubMed ID: 10355066 [TBL] [Abstract][Full Text] [Related]
5. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum]. Veselka J Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555 [TBL] [Abstract][Full Text] [Related]
6. Management of hypertrophic cardiomyopathy in children. Seggewiss H; Rigopoulos A Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624 [TBL] [Abstract][Full Text] [Related]
7. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature. Veselka J Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660 [TBL] [Abstract][Full Text] [Related]
10. Who and how to treat with non-surgical myocardial reduction therapy in hypertrophic cardiomyopathy: long-term outcomes. Martin WA; Sigwart U Heart Fail Monit; 2002; 3(1):15-27. PubMed ID: 12634884 [TBL] [Abstract][Full Text] [Related]
11. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Fananapazir L; Cannon RO; Tripodi D; Panza JA Circulation; 1992 Jun; 85(6):2149-61. PubMed ID: 1350522 [TBL] [Abstract][Full Text] [Related]
12. Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing. Park MH; Gilligan DM; Bernardo NL; Topaz O Angiology; 1999 Feb; 50(2):87-94. PubMed ID: 10063938 [TBL] [Abstract][Full Text] [Related]
13. Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Merrill WH; Friesinger GC; Graham TP; Byrd BF; Drinkwater DC; Christian KG; Bender HW Ann Thorac Surg; 2000 Jun; 69(6):1732-5; discussion 1735-6. PubMed ID: 10892916 [TBL] [Abstract][Full Text] [Related]
15. [Current respective role of surgery and permanent endocavitary stimulation in the treatment of hypertrophic cardiomyopathies]. Millaire A; de Groote P; Decoulx E; Ducloux G Ann Cardiol Angeiol (Paris); 1995 May; 44(5):226-33. PubMed ID: 7639504 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563 [TBL] [Abstract][Full Text] [Related]
17. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis. Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430 [TBL] [Abstract][Full Text] [Related]